USNA - USANA Health Sciences, Inc.
NEXT EARNINGS:
Apr 28, 2026
EPS Est: $0.44
|
Rev Est: $240.9M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$35.00
DETAILS
HIGH:
$35.00
LOW:
$35.00
MEDIAN:
$35.00
CONSENSUS:
$35.00
UPSIDE:
61.59%
Market Cap:
395.96M
Volume:
133,213
Avg Volume:
135,115
52 Week Range:
18.48-38.32
Sector:
Consumer Defensive
Industry:
Packaged Foods
Beta:
0.64
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
1,700
IPO Date:
1994-04-04
EPS (TTM):
0.58
P/E Ratio:
33.56
Revenue (TTM):
925.26M
Total Assets:
742.91M
Total Debt:
14.00M
Cash & Equiv:
158.38M
Rev Growth (5Y):
-4.0%
EPS Growth (5Y):
-37.1%
FCF Growth (5Y):
-15.6%
ROCE:
8.3%
Debt/Equity:
0.03
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $0.60 | $0.41 | +46.3% | $226.2M | $226.0M | +0.1% |
| 2025-10-21 | $-0.15 | $0.25 | -160.0% | $213.7M | $219.8M | -2.8% |
| 2025-07-22 | $0.74 | $0.54 | +37.0% | $235.8M | $225.8M | +4.4% |
| 2025-04-22 | $0.73 | $0.70 | +4.3% | $249.5M | $220.4M | +13.2% |
| 2025-02-25 | $0.64 | $0.49 | +30.6% | $213.6M | $208.8M | +2.3% |
| 2024-10-22 | $0.56 | $0.49 | +14.3% | $200.2M | $208.8M | -4.1% |
| 2024-07-23 | $0.54 | $0.65 | -16.9% | $212.9M | $221.0M | -3.7% |
| 2024-04-30 | $0.86 | $0.69 | +24.6% | $227.8M | $226.8M | +0.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 925.26M | 854.50M | 921.01M | 998.60M | 1.19B | 1.13B | 1.06B | 1.19B | 1.05B | 1.01B | 918.50M | 790.47M |
| Net Income | 10.76M | 42.03M | 63.79M | 69.35M | 116.50M | 124.66M | 100.53M | 126.22M | 62.53M | 100.04M | 94.67M | 76.64M |
| EPS | 0.58 | 2.20 | 3.33 | 3.60 | 5.78 | 5.89 | 4.44 | 5.36 | 2.60 | 4.09 | 3.71 | 3.11 |
| Total Assets | 742.91M | 748.19M | 632.76M | 596.55M | 577.74M | 640.89M | 516.93M | 554.46M | 519.27M | 470.64M | 423.24M | 350.58M |
| Total Debt | 14.00M | 39.20M | 13.21M | 13.78M | 17.30M | 21.47M | 25.60M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 158.38M | 181.77M | 330.42M | 288.42M | 239.83M | 312.88M | 234.83M | 214.33M | 247.13M | 175.77M | 143.21M | 111.13M |
| Operating Cash Flow | N/A | 60.99M | 70.64M | 103.90M | 121.23M | 160.40M | 126.73M | 152.12M | 123.78M | 137.03M | 111.47M | 105.19M |
| Free Cash Flow | N/A | 50.92M | 56.15M | 93.50M | 108.46M | 145.31M | 110.16M | 140.69M | 110.56M | 104.33M | 87.74M | 84.76M |
| FCF per Share | N/A | 2.67 | 2.92 | 4.86 | 5.38 | 6.91 | 4.87 | 5.97 | 4.60 | 4.26 | 3.51 | 3.35 |
| Book Value | 533.10M | 532.11M | 497.20M | 434.47M | 395.12M | 441.65M | 351.71M | 391.15M | 363.21M | 325.29M | 280.85M | 230.16M |
| Cash & ST Investments | 158.38M | 181.77M | 330.42M | 288.42M | 239.83M | 312.88M | 234.83M | 277.87M | 247.13M | 175.77M | 143.21M | 111.13M |
| ROC Equity | 0.02 | 0.08 | 0.13 | 0.16 | 0.29 | 0.28 | 0.29 | 0.32 | 0.17 | 0.31 | 0.34 | 0.33 |